India's GLP-1 market is set for a massive boom. Following patent expiry, generic versions of semaglutide are launching at ...

GoodRx reports that the FDA has approved oral semaglutide (Wegovy) for weight loss, offering an alternative to injections ...

A new pill, enlicitide, reduced LDL (“bad”) cholesterol by about 60% in a large clinical trial, matching the power of ...

This Morning's Ashley James has said she is "absolutely devastated" after she was targeted by online scammers who used AI ...

This Morning star Ashley James has responded after AI was used to create a disturbing advert with her likeness, promoting ...

ASHLEY James has become a victim of AI after a video has been circulated online claiming she’s taking weight loss pills. The ...

Use BBC.com or the new BBC App to listen to BBC podcasts, Radio 4 and the World Service outside the UK.

An internal study, based on February data from market researcher Circana, found 15% of U.S. households use GLP-1s, representing 17.5% of chocolate sales.

This is read by an automated voice. Please report any issues or inconsistencies here. Telehealth company Hims & Hers dropped its plan to offer a knockoff version of ...

Novo Nordisk is dismissing its patent infringement lawsuit against telehealth company Hims & Hers, as the two companies have reached an agreement that will see Novo Nordisk's branded weight loss ...

Novo Nordisk is dismissing its patent infringement lawsuit against telehealth company Hims & Hers, as the two companies have reached an agreement that will see Novo Nordisk’s branded weight loss ...